References
- Bygdeman M., Ganguli A., Kinoshita K., Lundström V. Development of a vaginal suppository suitable for single administration for interruption of second trimester abortion. Contraception 1976; 15: 129
- Bygdeman M., Christensen N., Green K., Lundström V. Mid-trimester abortion by vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene-PGE2. Contraception 1980; 22: 153
- Bygdeman M., Bremme K., Christensen N., Lundström V., Green K. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation. Contraception 1980; 22: 471
- Frankman O., Bygdeman M., Green K., Moberg P., Sandberg C.-G. Dilatation of the cervix prior to vacuum aspiration by single vaginal administration of 15-methyl-PGF2α, methyl ester. Contraception 1980; 21: 571
- Karim S. M. M., Ratnam S. S. Termination of abnormal intrauterine pregnancy with prostaglandins. Practical Applications of Prostaglandins and Their Synthesis Inhibitors, S. M. M. Karim. MTP Press Ltd., Lancaster 1979; 319
- Saarikoski S., Slander K., Pystynen P. Induction of labour with sulprostone after foetal death and in hydatiform mole. Prostaglandins 1980; 20: 481
- Southern E. M., Gutknecht G. D., Mohberg N. R., Edelman D. A. Vaginal prostaglandin E2 in the management of fetal intrauterine death. Br J Obstet Gynaecol 1978; 85: 437
- Toppozada M., Warda A., Ramadan M. Intramuscular 16-phenoxy PGE2 ester for pregnancy termination. Prostaglandins 1979; 17: 461